Compliant Analysis of Patient Samples and Data

Launched by SEQUENOM, INC. · Apr 27, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how leftover samples and data from patients can be used to help research conditions related to pregnancy, cancer, and infectious diseases. If you have provided a sample to LabCorp or one of its partners, your de-identified information (which means your personal details are removed to protect your privacy) may be used for this research. The study is currently recruiting participants and is open to individuals of all ages and genders who meet specific criteria.

To be eligible for this trial, individuals must either be of scientific interest to the researchers or their doctor and must provide written consent for their samples and data to be used. It's important to note that this trial will not include anyone from states or countries where local laws limit the use of such data for research. Participants can expect that their information will be handled carefully and confidentially, allowing researchers to better understand these health conditions while ensuring privacy is maintained.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Arm 1
• • All samples and data are de-identified and HIPAA compliant
• • Arm 2
• • Subject is of scientific interest to the Sponsor or treating physician
• • Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.
• Exclusion Criteria:
• • Arm 1
• • Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
• • Arm 2
• • Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent